|
1
|
Trewartha D and Carter K: Advances in
prostate cancer treatment. Nat Rev Drug Discov. 12:823–824. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lonergan PE and Tindall DJ: Androgen
receptor signaling in prostate cancer development and progression.
J Carcinog. 10:202011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Madan RA and Arlen PM: Recent advances
revolutionize treatment of metastatic prostate cancer. Future
Oncol. 9:1133–1144. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
el-Rayes BF, Shields AF, Vaitkevicius V
and Philip PA: Developments in the systemic therapy of pancreatic
cancer. Cancer Invest. 21:73–86. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Gray SG, Baird AM, O'Kelly F, Nikolaidis
G, Almgren M, Meunier A, Dockry E, Hollywood D, Ekström TJ, Perry
AS and O'Byrne KJ: Gemcitabine reactivates epigenetically silenced
genes and functions as a DNA methyltransferase inhibitor. Int J Mol
Med. 30:1505–1511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Srinivasan M, Banerjee S, Palmer A, Zheng
G, Chen A, Bosland MC, Kajdacsy-Balla A, Kalyanasundaram R and
Munirathinam G: HMGB1 in hormone-related cancer: A potential
therapeutic target. Horm Cancer. 5:127–139. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Tang D, Kang R, Cheh CW, Livesey KM, Liang
X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, et
al: HMGB1 release and redox regulates autophagy and apoptosis in
cancer cells. Oncogene. 29:5299–5310. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Bierhaus A, Schiekofer S, Schwaninger M,
Andrassy M, Humpert PM, Chen J, Hong M, Luther T, Henle T, Klöting
I, et al: Diabetes-associated sustained activation of the
transcription factor nuclear factor-kappaB. Diabetes. 50:2792–2808.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Tang D, Kang R, Livesey KM, Kroemer G,
Billiar TR, Van Houten B, Zeh HJ III and Lotze MT: High-mobility
group box 1 is essential for mitochondrial quality control. Cell
Metab. 13:701–711. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Tang D, Kang R, Livesey KM, Cheh CW,
Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ III
and Lotze MT: Endogenous HMGB1 regulates autophagy. J Cell Biol.
190:881–892. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Livesey KM, Tang D, Zeh HJ and Lotze MT:
Autophagy inhibition in combination cancer treatment. Curr Opin
Investig Drugs. 10:1269–1279. 2009.PubMed/NCBI
|
|
12
|
White E and DiPaola RS: The double-edged
sword of autophagy modulation in cancer. Clin Cancer Res.
15:5308–5316. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu
Y, Xie M, Yin X, Livesey KM, Lotze MT, et al: HMGB1-induced
autophagy promotes chemotherapy resistance in leukemia cells.
Leukemia. 25:23–31. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Qian HR and Yang Y: Functional role of
autophagy in gastric cancer. Oncotarget. 7:17641–17651. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mancias JD and Kimmelman AC: Mechanisms of
selective autophagy in normal physiology and cancer. J Mol Biol.
428:1659–1680. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen K and Shi W: Autophagy regulates
resistance of non-small cell lung cancer cells to paclitaxel.
Tumour Biol. 37:10539–10544. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Rocchi A and He C: Emerging roles of
autophagy in metabolism and metabolic disorders. Front Biol
(Beijing). 10:154–164. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Liu W, Zhang Z, Zhang Y, Chen X, Guo S,
Lei Y, Xu Y, Ji C, Bi Z and Wang K: HMGB1-mediated autophagy
modulates sensitivity of colorectal cancer cells to oxaliplatin via
MEK/ERK signaling pathway. Cancer Biol Ther. 16:511–517. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Huang J, Ni J, Liu K, Yu Y, Xie M, Kang R,
Vernon P, Cao L and Tang D: HMGB1 promotes drug resistance in
osteosarcoma. Cancer Res. 72:230–238. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Narumi T, Shishido T, Otaki Y, Kadowaki S,
Honda Y, Funayama A, Honda S, Hasegawa H, Kinoshita D, Yokoyama M,
et al: High-mobility group box 1-mediated heat shock protein beta 1
expression attenuates mitochondrial dysfunction and apoptosis. J
Mol Cell Cardiol. 82:1–12. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Acunzo J, Katsogiannou M and Rocchi P:
Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and
HSP22 (HspB8) as regulators of cell death. Int J Biochem Cell Biol.
44:1622–1631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wirth M, Joachim J and Tooze SA:
Autophagosome formation-the role of ULK1 and Beclin1-PI3KC3
complexes in setting the stage. Semin Cancer Biol. 23:301–309.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kang R, Livesey KM, Zeh HJ III, Lotze MT
and Tang D: Metabolic regulation by HMGB1-mediated autophagy and
mitophagy. Autophagy. 7:1256–1258. 2011. View Article : Google Scholar : PubMed/NCBI
|
